12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Dynegy Inc. (DYN)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (DYN) is currently associated with the following stock: Dyne Therapeutics Inc. (DYN)
Sector: Electric Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Brevan Howard Alan Howard | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.16 | 15,000 | $107,400.00 | 720,506 | 2017-03-24 | Filing | |
| $7.62 | 25,000 | $190,500.00 | 705,506 | 2017-03-09 | Filing | |
| $8.21 | 12,500 | $102,678.75 | 429,462 | 2016-11-04 | Filing | |
| $10.08 | 10,000 | $100,800.00 | 436,763 | 2016-03-01 | Filing | |
| $11.61 | 6,400 | $74,304.00 | 45,023 | 2015-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.79 | 5,250,000 | $61,897,500.00 | 14,291,152 | 2018-01-09 | Filing | |
| $32.28 | 250,000 | $8,070,000.00 | 8,927,023 | 2015-06-02 | Filing | |
| $32.45 | 50,000 | $1,622,500.00 | 9,177,023 | 2015-06-01 | Filing | |
| $32.50 | 1,050,000 | $34,125,000.00 | 9,227,023 | 2015-05-27 | Filing | |
| $32.48 | 150,000 | $4,872,000.00 | 10,277,023 | 2015-05-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,564 | $110,089 | 0% | |
| 2. | 1 | $1 | 0% |
News See All
Dyne's Investigational DMD Drug DYNE-251 Gets Japan Orphan Drug Status After Strong Trial Data
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the best stocks to buy under $20.
10 Best Stocks to Buy Under $20
On September 16, Ali Dibadj, Janus Henderson Investors CEO, joined 'Squawk Box' on CNBC to discuss the latest market trends and suggest that small and mid-cap stocks have enormous potential to deliver...
Raymond James Increases PT on Dyne Therapeutics Stock from $31 to $35, Maintains Buy Rating
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 14 Best Small Cap Stocks to Buy Right Now. On August 25, Raymond James increased the price target on Dyne Therapeutics, Inc.
14 Best Small Cap Stocks to Buy Right Now
The S&P 600 and S&P BSE Small Cap indexes had soared 0.29% and 0.30%, respectively, while the Russell 2000 has jumped nearly 0.48% as of September 8. The U.S.
Morgan Stanley Reiterates a Buy Rating on Dyne Therapeutics (DYN), Keeps the PT
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the Best Small-Cap Growth Stocks to Buy Right Now. On August 4, Michael Ulz of Morgan Stanley reiterated a Buy rating on Dyne Therapeutics, Inc.
11 Best Small-Cap Growth Stocks to Buy Right Now
On August 14, Jonathan Krinsky of BTIG joined CNBC for an interview to discuss the sustainability of the recent small-cap rally.
Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for Duchenne Muscular Dystrophy Therapy
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the best small cap stocks with biggest upside potential.
9 Best Small Cap Stocks with Biggest Upside Potential
On August 14, Jonathan Krinsky of BTIG, joined 'Closing Bell' on CNBC to discuss whether the recent rally in small cap stocks is sustainable.
13 Best Healthcare Stocks to Buy Under $10
On June 27, Tiffany McGhee, CEO of Pivotal Advisors, appeared on CNBC to talk about the best course of action for investors amid current market dynamics.
Hedge Fund Resource Center Billionaire Hedge Funds
